Epidemiological trends and burden analysis of cervical cancer attributable to unsafe sex: A population-based study from 1990 to 2019.
cancer burden
cervical cancer
disability‐adjusted life years
global burden of disease (GBD)
unsafe sex
Journal
Public health nursing (Boston, Mass.)
ISSN: 1525-1446
Titre abrégé: Public Health Nurs
Pays: United States
ID NLM: 8501498
Informations de publication
Date de publication:
25 Jul 2024
25 Jul 2024
Historique:
revised:
12
06
2024
received:
05
05
2024
accepted:
11
07
2024
medline:
26
7
2024
pubmed:
26
7
2024
entrez:
26
7
2024
Statut:
aheadofprint
Résumé
Unsafe sex is recognized as an important risk factor for cervical cancer (CC). Understanding the global disease burden of CC attributable to unsafe sex can assist policymakers in allocating healthcare resources. Data were obtained from the 2019 global burden of disease database (GBD). We examined global, regional, and national levels of CC mortality, disability-adjusted life years (DALYs), and age-standardized rates (ASRs) caused by unsafe sex. ASRs were evaluated using estimated annual percentage changes (EAPCs). Attributable to unsafe sex, there were 280,479 CC-related deaths in 2019 and 8,955,013 CC-related DALYs. In the period 1990-2019, the global ASRs of CC due to unsafe sex decreased around the world; for age-standardized mortality rate (ASMR) and age-standardized DALY rate (ASDR), the EAPCs were -0.93 and -0.95. The highest ASMRs and ASDRs were found in central sub-Saharan Africa and the lowest in Australasia. In the past few decades, the ASMR and ASDR of CC caused by unsafe sexual practices have decreased over time, with significant variations observed among different countries and regions. Increased focus is needed on spreading awareness about sexual health and promoting CC prevention and screening, particularly in low- and middle-income nations.
Sections du résumé
BACKGROUND
BACKGROUND
Unsafe sex is recognized as an important risk factor for cervical cancer (CC). Understanding the global disease burden of CC attributable to unsafe sex can assist policymakers in allocating healthcare resources.
METHODS
METHODS
Data were obtained from the 2019 global burden of disease database (GBD). We examined global, regional, and national levels of CC mortality, disability-adjusted life years (DALYs), and age-standardized rates (ASRs) caused by unsafe sex. ASRs were evaluated using estimated annual percentage changes (EAPCs).
RESULTS
RESULTS
Attributable to unsafe sex, there were 280,479 CC-related deaths in 2019 and 8,955,013 CC-related DALYs. In the period 1990-2019, the global ASRs of CC due to unsafe sex decreased around the world; for age-standardized mortality rate (ASMR) and age-standardized DALY rate (ASDR), the EAPCs were -0.93 and -0.95. The highest ASMRs and ASDRs were found in central sub-Saharan Africa and the lowest in Australasia.
CONCLUSION
CONCLUSIONS
In the past few decades, the ASMR and ASDR of CC caused by unsafe sexual practices have decreased over time, with significant variations observed among different countries and regions. Increased focus is needed on spreading awareness about sexual health and promoting CC prevention and screening, particularly in low- and middle-income nations.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Guangdong Science and Technology
ID : 2022A1414020007
Organisme : Science and Technology Planning Project of Guangdong Province
Informations de copyright
Public Health Nursing© 2024 The Author(s). Public Health Nursing published by Wiley Periodicals LLC.
Références
Achoki, T., Sartorius, B., Watkins, D., Glenn, S. D., Kengne, A. P., Oni, T., Wiysonge, C. S., Walker, A., Adetokunboh, O. O., Babalola, T. K., Bolarinwa, O. A., Claassens, M. M., Cowden, R. G., Day, C. T., Ezekannagha, O., Ginindza, T. G., Iwu, C. C. D., Iwu, C. J., Karangwa, I., … Naghavi, M. (2022). Health trends, inequalities and opportunities in South Africa's provinces, 1990–2019: Findings from the Global Burden of Disease 2019 Study. Journal of Epidemiology and Community Health, 76(5), 471–481. Published online January 19, 2022. https://doi.org/10.1136/jech‐2021‐217480
Arbyn, M., Weiderpass, E., Bruni, L., De Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2020). Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis [published correction appears in Lancet Glob Health. 2022 Jan;10(1):e41]. The Lancet Global Health, 8(2), e191–e203. https://doi.org/10.1016/S2214‐109X(19)30482‐6
Bray, F., Jemal, A., Grey, N., Ferlay, J., & Forman, D. (2012). Global cancer transitions according to the Human Development Index (2008‐2030): A population‐based study. The Lancet Oncology, 13(8), 790–801. https://doi.org/10.1016/S1470‐2045(12)70211‐5
Buskwofie, A., David‐West, G., & Clare, C. A. (2020). A review of cervical cancer: Incidence and disparities. Journal of the National Medical Association, 112(2), 229–232. https://doi.org/10.1016/j.jnma.2020.03.002
Cowan, S. A., Gerstoft, J., Haff, J., Christiansen, A. H., Nielsen, J., & Obel, N. (2012). Stable incidence of HIV diagnoses among Danish MSM despite increased engagement in unsafe sex. Journal of Acquired Immune Deficiency Syndromes, 61(1), 106–111. https://doi.org/10.1097/QAI.0b013e31825af890
Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013). Human papillomavirus and cervical cancer. Lancet, 382(9895), 889–899. https://doi.org/10.1016/S0140‐6736(13)60022‐7
De Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., & Bosch, F. X. (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta‐analysis. The Lancet Infectious Diseases, 7(7), 453–459. https://doi.org/10.1016/S1473‐3099(07)70158‐5
Epstein, R. J. (2005). Primary prevention of human papillomavirus‐dependent neoplasia: No condom, no sex. European Journal of Cancer, 41(17), 2595–2600. https://doi.org/10.1016/j.ejca.2005.06.023
Evans, W., Kadirov, K., Thior, I., Ganesan, R., Ulasevich, A., & Deperthes, B. (2018). Willingness to pay for condoms among men in Sub‐Saharan Africa. International Journal of Environmental Research and Public Health, 16(1), 34. Published 2018 Dec 24. https://doi.org/10.3390/ijerph16010034
Ferrand, J. L., Blashill, A. J., Corliss, H. L., & Walsh‐Buhi, E. R. (2021). Condom application skills and self‐efficacy in youth: A systematic review and meta‐analysis. PLoS ONE, 16(4), e0249753. Published 2021 Apr 8. https://doi.org/10.1371/journal.pone.0249753
Fitzmaurice, C., Abate, D., Abbasi, N., Abbastabar, H., Abd‐Allah, F., Abdel‐Rahman, O., Abdelalim, A., Abdoli, A., Abdollahpour, I., Abdulle, A. S. M., Abebe, N. D., Abraha, H. N., Abu‐Raddad, L. J., Abualhasan, A., Adedeji, I. A., Advani, S. M., Afarideh, M., M., Aghaali, M., … Murray, C. J. L. (2019). Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability‐adjusted life‐years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncology, 5(12), 1749–1768. https://doi.org/10.1001/jamaoncol.2019.2996
GBD 2019 Diseases and Injuries Collaborators. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019 [published correction appears in Lancet. 2020 Nov 14;396(10262):1562]. Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140‐6736(20)30925‐9
Haagsma, J. A., James, S. L., Castle, C. D., Dingels, Z. V., Fox, J. T., Hamilton, E. B., Liu, Z., Lucchesi, L. R., Roberts, N. L. S., Sylte, D. O., Adebayo, O. M., Ahmadi, A., Ahmed, M. B., Aichour, M. T. E., Alahdab, F., Alghnam, S. A., Aljunid, S. M., Al‐Raddadi, R. M., Alsharif, U., … Vos, T. (2020). Burden of injury along the development spectrum: Associations between the Socio‐demographic Index and disability‐adjusted life year estimates from the Global Burden of Disease Study 2017 [published correction appears in Inj Prev. 2020 Oct;26(Supp 1):i164]. Injury Prevention, 26(Supp 1), i12–i26. https://doi.org/10.1136/injuryprev‐2019‐043296
Heijkoop, S. T., Nout, R. A., Quint, S., Mens, J. W. M., Heijmen, B. J. M., & Hoogeman, M. S. (2017). Dynamics of patient reported quality of life and symptoms in the acute phase of online adaptive external beam radiation therapy for locally advanced cervical cancer. Gynecologic Oncology, 147(2), 439–449. https://doi.org/10.1016/j.ygyno.2017.08.009
Hodgins, C., Stannah, J., Kuchukhidze, S., Zembe, L., Eaton, J. W., Boily, M.‐C., & Maheu‐Giroux, M. (2022). Population sizes, HIV prevalence, and HIV prevention among men who paid for sex in sub‐Saharan Africa (2000‐2020): A meta‐analysis of 87 population‐based surveys. PLoS Medicine, 19(1), e1003861. Published 2022 Jan 25. https://doi.org/10.1371/journal.pmed.1003861
Horvath, S., & Schreiber, C. A. (2017). Unintended pregnancy, induced abortion, and mental health. Current Psychiatry Reports, 19(11), 77. Published 2017 Sep 14. https://doi.org/10.1007/s11920‐017‐0832‐4
Mapanga, W., Girdler‐Brown, B., & Singh, E. (2019). Knowledge, attitudes and practices of young people in Zimbabwe on cervical cancer and HPV, current screening methods and vaccination. BMC Cancer, 19(1), 845. Published 2019 Aug 28. https://doi.org/10.1186/s12885‐019‐6060‐z
Mwangi, M., Bunnell, R., Nyoka, R., Gichangi, A., Makokha, E., Kim, A., Kichamu, G., Marum, L., Ichwara, J., & Mermin, J. (2011). Unsafe sex among HIV‐infected adults in Kenya: Results of a nationally representative survey. Journal of Acquired Immune Deficiency Syndromes, 58(1), 80–88. https://doi.org/10.1097/QAI.0b013e3182251001
Nakazawa, H., Yamaguchi, S., Onuki, M., Kitai, M., Yahata, H., Aoki, Y., Horie, K., Mimura, T., Okadome, M., Kato, H., Takehara, K., Kamiura, S., Shigeta, S., & Matsumoto, K. (2023). Age at first sexual intercourse among young women with invasive cervical cancer: implications for routine vaccination against human papillomavirus in Japan. Japanese Journal of Clinical Oncology, 53(6), 530–533. https://doi.org/10.1093/jjco/hyad017
Ng'uni, T., Chasara, C., & Ndhlovu, Z. M. (2020). Major scientific hurdles in HIV vaccine development: Historical perspective and future directions. Frontiers in Immunology, 11, 590780. Published 2020 Oct 28. https://doi.org/10.3389/fimmu.2020.590780
Olusola, P., Banerjee, H. N., Philley, J. V., & Dasgupta, S. (2019). Human papilloma virus‐associated cervical cancer and health disparities. Cells, 8(6), 622. Published 2019 Jun 21. https://doi.org/10.3390/cells8060622
Reilly, T., Woodruff, S. I., Smith, L., Clapp, J. D., & Cade, J. (2010). Unsafe sex among HIV positive individuals: Cross‐sectional and prospective predictors. Journal of Community Health, 35(2), 115–123. https://doi.org/10.1007/s10900‐009‐9203‐3
Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., Degen, O., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., Raben, D., Coll, P., Antinori, A., Nwokolo, N., Rieger, A., Prins, J. M., Blaxhult, A., Weber, R., Van Eeden, A., … Janeiro, N. (2019). Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV‐positive partner taking suppressive antiretroviral therapy (PARTNER): Final results of a multicentre, prospective, observational study. Lancet, 393(10189), 2428–2438. https://doi.org/10.1016/S0140‐6736(19)30418‐0
Sadigov, R. (2022). Rapid growth of the world population and its socioeconomic results. The Scientific World Journal, 2022, 8110229. Published 2022 Mar 23. https://doi.org/10.1155/2022/8110229
Saraiya, M., Unger, E. R., Thompson, T. D., Lynch, C. F., Hernandez, B. Y., Lyu, C. W., Steinau, M., Watson, M., Wilkinson, E. J., Hopenhayn, C., Copeland, G., Cozen, W., Peters, E. S., Huang, Y., Saber, M. S., Altekruse, S., & Goodman, M. T. (2015). US assessment of HPV types in cancers: Implications for current and 9‐valent HPV vaccines. JNCI: Journal of the National Cancer Institute, 107(6):djv086. Published 2015 Apr 29. https://doi.org/10.1093/jnci/djv086
Shrader, C.‐H., Peters Jefferson, K., Kanamori, M., Rochat, R., & Siegler, A. (2021). “I'd Rather Use a Refuse Bag:” A qualitative exploration of a south African community's perceptions of government‐provided condoms and participant‐preferred solutions. Archives of Sexual Behavior, 50(2), 615–627. https://doi.org/10.1007/s10508‐020‐01701‐2
Shrestha, G., Thakur, R. K., Singh, R., Mulmi, R., Shrestha, A., & Pradhan, P. M. S. (2021). Cancer burden in Nepal, 1990–2017: An analysis of the Global Burden of Disease study. PLoS ONE, 16(8), e0255499. Published 2021 Aug 3. https://doi.org/10.1371/journal.pone.0255499
Simms, K. T., Steinberg, J., Caruana, M., Smith, M. A., Lew, J.‐B., Soerjomataram, I., Castle, P. E., Bray, F., & Canfell, K. (2019). Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study. The Lancet Oncology, 20(3), 394–407. https://doi.org/10.1016/S1470‐2045(18)30836‐2
Singh, D., Vignat, J., Lorenzoni, V., Eslahi, M., Ginsburg, O., Lauby‐Secretan, B., Arbyn, M., Basu, P., Bray, F., & Vaccarella, S. (2023). Global estimates of incidence and mortality of cervical cancer in 2020: A baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. The Lancet Global Health, 11(2), e197–e206. https://doi.org/10.1016/S2214‐109X(22)00501‐0
Singh, G. (2012). Global inequalities in cervical cancer incidence and mortality are linked to deprivation, low socioeconomic status, and human development. International Journal of Maternal and Child Health and AIDS, 1(1), 17–30. https://doi.org/10.21106/ijma.12
Sung, B., Phau, I., Cheah, I., & Teah, K. (2020). Critical success factors of public health sponsorship in Australia. Health Promotion International, 35(1), 42–49. https://doi.org/10.1093/heapro/day107
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Vaccarella, S., Bruni, L., & Seoud, M. (2013). Burden of human papillomavirus infections and related diseases in the extended Middle East and North Africa region. Vaccine, 31(Suppl 6), G32–G44. https://doi.org/10.1016/j.vaccine.2012.06.098
Vaccarella, S., Laversanne, M., Ferlay, J., & Bray, F. (2017). Cervical cancer in Africa, Latin America and the Caribbean and Asia: Regional inequalities and changing trends. International Journal of Cancer, 141(10), 1997–2001. https://doi.org/10.1002/ijc.30901
Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., Snijders, P. J., Peto, J., Meijer, C. J., & Muñoz, N. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189(1), 12–19. https://doi.org/10.1002/(SICI)1096‐9896(199909)189:1<12::AID‐PATH431>3.0.CO;2‐F
Wentzensen, N., & Schiffman, M. (2018). Accelerating cervical cancer control and prevention. Lancet Public Health, 3(1), e6–e7. https://doi.org/10.1016/S2468‐2667(17)30242‐6
Yu, L., Lanqing, G., Huang, Z., Xin, X., Minglin, L., Fa‐Hui, L., Zou, H., & Min, J. (2023). T cell immunotherapy for cervical cancer: challenges and opportunities. Frontiers in Immunology, 14, 1105265. Published 2023 Apr 26. https://doi.org/10.3389/fimmu.2023.1105265